NFJ Investment Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.56M | Sell |
184,849
-32,222
| -15% | -$1.49M | 0.3% | 95 |
|
2025
Q1 | $13.2M | Sell |
217,071
-5,018
| -2% | -$306K | 0.45% | 73 |
|
2024
Q4 | $12.6M | Buy |
+222,089
| New | +$12.6M | 0.4% | 80 |
|
2023
Q4 | – | Sell |
-32,522
| Closed | -$1.89M | – | 222 |
|
2023
Q3 | $1.89M | Sell |
32,522
-74
| -0.2% | -$4.3K | 0.06% | 183 |
|
2023
Q2 | $2.08M | Buy |
32,596
+4,099
| +14% | +$262K | 0.06% | 200 |
|
2023
Q1 | $1.98M | Sell |
28,497
-108
| -0.4% | -$7.49K | 0.05% | 227 |
|
2022
Q4 | $2.06M | Sell |
28,605
-181,955
| -86% | -$13.1M | 0.05% | 237 |
|
2022
Q3 | $7.08M | Buy |
210,560
+177,153
| +530% | +$5.95M | 0.18% | 170 |
|
2022
Q2 | $2.57M | Sell |
33,407
-108
| -0.3% | -$8.32K | 0.06% | 245 |
|
2022
Q1 | $2.45M | Buy |
33,515
+722
| +2% | +$52.7K | 0.05% | 271 |
|
2021
Q4 | $2.05M | Sell |
32,793
-1,759
| -5% | -$110K | 0.04% | 314 |
|
2021
Q3 | $2.04M | Sell |
34,552
-697
| -2% | -$41.2K | 0.04% | 320 |
|
2021
Q2 | $2.36M | Sell |
35,249
-3,554
| -9% | -$237K | 0.04% | 311 |
|
2021
Q1 | $2.45M | Buy |
+38,803
| New | +$2.45M | 0.05% | 298 |
|